Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Virologic and Immunologic Characteristics of Severe Mpox in Persons With Advanced HIV

NCT06045923 is registered in ClinicalTrials.gov with Centers for Disease Control and Prevention as lead sponsor.

NCT NCT06045923
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT06045923 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Virologic and Immunologic Characteristics of Severe Mpox in Persons With Advanced HIV
Lead sponsor
Centers for Disease Control and Prevention
Phase
Observational
Overall status
Terminated
Start date
March 17, 2023
Completion date
January 1, 2026
Enrollment
100 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

aids, hiv infections, monkeypox